These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 4023387)

  • 21. [Agranulocytosis caused by ticlopidine].
    del Rey Moreno J; López Cortés LF; Gómez Mateos JM; Lozano de León F
    Neurologia; 1992 May; 7(5):121-2. PubMed ID: 1389293
    [No Abstract]   [Full Text] [Related]  

  • 22. Agranulocytosis caused by ticlopidine and its mechanism.
    Ono K; Kurohara K; Yoshihara M; Shimamoto Y; Yamaguchi M
    Am J Hematol; 1991 Aug; 37(4):239-42. PubMed ID: 1858780
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Agranulocytosis caused by ticlopidine].
    Legarra G; Beltrán de Heredia JM; Olabarría I; Menoyo MV; Villarreal JJ
    Sangre (Barc); 1994 Jun; 39(3):229-30. PubMed ID: 7524171
    [No Abstract]   [Full Text] [Related]  

  • 24. Agranulocytosis associated with yohimbine use.
    Siddiqui MA; More-O'Ferrall D; Hammod RS; Baime RV; Staddon AP
    Arch Intern Med; 1996 Jun; 156(11):1235-6, 1238. PubMed ID: 8639019
    [No Abstract]   [Full Text] [Related]  

  • 25. Spinal subarachnoid hematoma after lumbar puncture in a patient receiving antiplatelet therapy.
    Mayumi T; Dohi S
    Anesth Analg; 1983 Aug; 62(8):777-9. PubMed ID: 6869865
    [No Abstract]   [Full Text] [Related]  

  • 26. Necrotizing gingivitis: a possible oral manifestation of ticlopidine-induced agranulocytosis.
    Rajandram RK; Ramli R; Karim F; Rahman RA; Fun LC
    N Z Med J; 2007 Jun; 120(1256):U2590. PubMed ID: 17589558
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Incidence, etiology and bone marrow characteristics of non-chemotherapy-induced agranulocytosis.
    Apinantriyo B; Lekhakula A; Rujirojindakul P
    Hematology; 2011 Jan; 16(1):50-3. PubMed ID: 21269568
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The influence of ticlopidine on the natural course of retinal vein occlusion.
    Houtsmuller AJ; Vermeulen JA; Klompe M; Zahn KJ; Henkes HE; Baarsma GS; Tijssen J
    Agents Actions Suppl; 1984; 15():219-29. PubMed ID: 6385648
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ticlopidine: quo vadis? Subarachnoid hemorrhage.
    Ono H; Mizukami M; Kitamura K; Kikuchi H
    Agents Actions Suppl; 1984; 15():259-72. PubMed ID: 6385650
    [No Abstract]   [Full Text] [Related]  

  • 30. [Adverse hematologic effects of ticlopidine].
    Lesesve JF; Noblet C; Stamatoullas A; Gueit I; Moore N; Monconduit M
    Therapie; 1995; 50(5):468-70. PubMed ID: 8571290
    [No Abstract]   [Full Text] [Related]  

  • 31. [Drug-induced agranulocytosis: clinical study of 19 cases].
    Márquez JA; Pardo C; Amutio E; Cortés C; Piñán MA; Alvarez C
    Sangre (Barc); 1998 Oct; 43(5):436-8. PubMed ID: 9868339
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ticlopidine-induced aplastic anemia: two new case reports, review, and meta-analysis of 55 additional cases.
    Symeonidis A; Kouraklis-Symeonidis A; Seimeni U; Galani A; Giannakoulas N; Fragopanagou E; Tiniakou M; Matsouka P; Zoumbos N
    Am J Hematol; 2002 Sep; 71(1):24-32. PubMed ID: 12221670
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chlorpropamide-induced agranulocytosis.
    Tucker SC; Lynch JP; Ansell BF
    JAMA; 1977 Aug; 238(5):422. PubMed ID: 577559
    [No Abstract]   [Full Text] [Related]  

  • 34. [Intrahepatic cholestasis and agranulocytosis in a young man: toxic reaction or citiolone?].
    Fernández Sanfiel ML; Gómez Sirvent JL; González Reimers E; Santolaria Fernández F; Boada Juárez JN; Batista López N; Ravina Cabrera M
    Rev Esp Enferm Apar Dig; 1988 Oct; 74(4 Pt 2):465-6. PubMed ID: 3217584
    [No Abstract]   [Full Text] [Related]  

  • 35. [Should ticlopidine be forbidden for hemodialysis patients waiting for renal transplantation?].
    Spiesser R; Lavenet F; Enon B; Jacob JP; Chapillon M; Riberi P
    Presse Med; 1985 Dec; 14(43):2197-8. PubMed ID: 2934730
    [No Abstract]   [Full Text] [Related]  

  • 36. Ticlopidine can cause chronic diarrhoea.
    Giardina MG; Matarazzo M; Cacciatore L; De Marco F
    Lancet; 1984 Feb; 1(8373):407. PubMed ID: 6141477
    [No Abstract]   [Full Text] [Related]  

  • 37. Agranulocytosis associated with aminoglutethimide: pharmacological and marrow studies.
    Harris AL; Hughes G; Barrett AJ; Abusrewil S; Dowsett M; Smith IE
    Br J Cancer; 1986 Jul; 54(1):119-22. PubMed ID: 3730249
    [No Abstract]   [Full Text] [Related]  

  • 38. [Does the use of ticlopidine in hemodialyzed patients contraindicate renal transplantation?].
    Louis J; Renoult E; Hurault De Ligny B; Vagner JC; Kessler M
    Presse Med; 1986 Feb; 15(8):399. PubMed ID: 2938165
    [No Abstract]   [Full Text] [Related]  

  • 39. [Use of ticlopidine in chronic hemodialyzed patients. Counter-indication in future renal transplant receivers].
    Lang P; Plaisant B; Benoit G; Brasseur L; Charpentier B; Fries D
    Presse Med; 1985 Apr; 14(16):894-5. PubMed ID: 3158926
    [No Abstract]   [Full Text] [Related]  

  • 40. [Agranulocytosis during a treatment with nitrendipine and ticlopidine].
    Lagier C; Vial T; Rabilloud M; Evreux JC
    Therapie; 1991; 46(2):169-70. PubMed ID: 2053096
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.